Literature DB >> 17524020

Lung disease in ataxia-telangiectasia.

L Bott1, Jp Lebreton, C Thumerelle, Jc Cuvellier, A Deschildre, A Sardet.   

Abstract

UNLABELLED: Ataxia-telangiectasia (AT) is a multi-systemic disease caused by mutational inactivation of the ATM gene. We report a retrospective study of lung disease in 15 patients. PATIENTS AND METHODS: A diagnosis of AT was made if the patient met the following criteria: neurological features and at least one the following: oculo-cutaneous telangiectasia, elevated serum alpha-feto-protein level.
RESULTS: Recurrent sino-pulmonary infections were usually present in 11 of the cases and occurred during the first 2 years of life. Other lung injuries noted were bronchiectasis, obstruction and restriction of the airways, fibrosis, pneumothorax and haemoptysis. Eleven children had immunodeficiencies. DISCUSSION: Recurrent sino-pulmonary manifestations precede neurological complications, but the severity of neuro-degeneration and pulmonary disease were not correlated. Pulmonary status was a prognosis factor. Immunodeficiency was the main, but not the only, aetiology for lung disease in AT.
CONCLUSION: There is little dispute over the role of ATM in lung and respiratory epithelium. To reduce the morbidity associated with AT, there needs to be greater awareness of respiratory complications. Early management and monitoring lung function is necessary to minimize lung damage.

Entities:  

Mesh:

Year:  2007        PMID: 17524020     DOI: 10.1111/j.1651-2227.2007.00338.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  18 in total

1.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.

Authors:  Rosanna Beraldi; Chun-Hung Chan; Christopher S Rogers; Attila D Kovács; David K Meyerholz; Constantin Trantzas; Allyn M Lambertz; Benjamin W Darbro; Krystal L Weber; Katherine A M White; Richard V Rheeden; Michael C Kruer; Brian A Dacken; Xiao-Jun Wang; Bryan T Davis; Judy A Rohret; Jason T Struzynski; Frank A Rohret; Jill M Weimer; David A Pearce
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

3.  Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Authors:  Matan Kraus; Atar Lev; Amos J Simon; Inbal Levran; Andrea Nissenkorn; Yonit B Levi; Yackov Berkun; Ori Efrati; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

4.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

5.  Pulmonary function in children and young adults with ataxia telangiectasia.

Authors:  Sharon A McGrath-Morrow; Howard M Lederman; Angela D Aherrera; Maureen A Lefton-Greif; Thomas O Crawford; Timothy Ryan; Jennifer Wright; Joseph M Collaco
Journal:  Pediatr Pulmonol       Date:  2013-02-08

6.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

7.  Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.

Authors:  Silvia Montella; Carmine Mollica; Andrea Finocchi; Andrea Pession; Maria Cristina Pietrogrande; Antonino Trizzino; Giusy Ranucci; Marco Maglione; Giuliana Giardino; Marco Salvatore; Francesca Santamaria; Claudio Pignata
Journal:  J Clin Immunol       Date:  2013-08-24       Impact factor: 8.317

8.  Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis.

Authors:  C J Harbort; Paulo Vitor Soeiro-Pereira; Horst von Bernuth; Angela M Kaindl; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Janine Reichenbach; Joachim Roesler; Arturo Zychlinsky; Borko Amulic
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

9.  TREC/KREC levels in children with ataxia-telangiectasia.

Authors:  Oksana Boyarchuk; Halyna Makukh; Larysa Kostyuchenko; Nataliya Yarema; Ivanna Haiboniuk; Volodymyr Kravets; Oleksandra Shulhai; Bohdan Tretyak
Journal:  Immunol Res       Date:  2021-08-24       Impact factor: 2.829

10.  Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.

Authors:  Tannaz Moeini Shad; Bahman Yousefi; Parisa Amirifar; Samaneh Delavari; William Rae; Parviz Kokhaei; Hassan Abolhassani; Asghar Aghamohammadi; Reza Yazdani
Journal:  J Clin Immunol       Date:  2020-10-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.